Back
MoonLake Immunotherapeutics Stock Predictions

Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
46
MLTX
MoonLake Immunotherapeutics
Last Price:
$38.63
Seasonality Move:
49.62%
7 Day Trial
ALL ACCESS PASS
$
7

Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatioMoonLake Immunotherapeutics Stock Forecast
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 103.5% based on the past 4 years of stock performance.
-
MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is MoonLake Immunotherapeutics Stock Undervalued?The current MoonLake Immunotherapeutics [MLTX] share price is $38.93. The Score for MLTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MLTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 103.5% based on the past 4 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Sell
46
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics overpriced?
-
MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
58.26
52-Week Low:
31.42
Prediction Charts
Market Cap:
2.5B
Price in USD:
38.93
Volume:
133.2K
Beta:
1.32
Technical Analysis
SMA50:
38.63
SMA100:
41.81
SMA200:
45.84
52-Wk Change:
-2.58%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?Yes, MoonLake Immunotherapeutics is a publicly traded company.
-
What is the MoonLake Immunotherapeutics stock quote today?The MoonLake Immunotherapeutics stock price is 38.93 USD today.
-
How to buy MoonLake Immunotherapeutics stock online?You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-6 | 41.52 | 39.27 | 41.53 | 38.66 |
May-7 | 39.43 | 37.60 | 39.43 | 37.05 |
May-8 | 37.70 | 39.74 | 40.12 | 36.75 |
May-9 | 39.74 | 38.47 | 40.75 | 38.07 |
May-12 | 39.17 | 40.18 | 40.86 | 39.17 |
May-13 | 40.58 | 38.54 | 41.10 | 38.31 |
May-14 | 38.66 | 36.99 | 39.50 | 36.35 |
May-15 | 36.98 | 37.66 | 37.76 | 36.05 |
May-16 | 37.65 | 37.62 | 38.31 | 36.69 |
May-19 | 38.85 | 39.20 | 40.49 | 37.76 |
May-20 | 39.39 | 40.28 | 40.43 | 39.12 |
May-21 | 39.83 | 38.54 | 40.22 | 38.47 |
May-22 | 38.21 | 38.51 | 38.79 | 37.79 |
May-23 | 38.01 | 38.93 | 39.08 | 37.92 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.26 per share, and a decrease next year of $0.56 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.